NUVB

3.8000.26%
GH

Gary Hattersley

Chief Scientific Officer

Dr. Gary Hattersley, Ph.D., serves as Chief Scientific Officer of Nuvation Bio Inc. since June 2019. He has been a Member of Scientific Advisory Board of Radius Health, Inc. since November 1, 2018. Dr. Hattersley served as Chief Scientific Officer of Radius Health, Inc. since January 9, 2014 until November 1, 2018 and served as its Senior Vice President until November 1, 2018 and served as its Senior Vice President of Preclinical Development from December 2011 to December 2013 and also served as Vice President of Biology. Dr. Hattersley serves as Senior Vice President of Preclinical Development at MPM Acquisition Corp. and served as its Vice President of Biology from May 2005 to December 2011. He served as Senior Director of Research at Radius Health, Inc. from 2006 to 2008. Dr. Hattersley has experiences in musculoskeletal research. He served as Senior Scientist of Millennium Pharmaceuticals, Inc. since 2000 until 2003, and responsible for the discovery and development of novel small-molecule agents for the treatment of osteoporosis and other metabolic bone diseases. He also held positions at Genetics Institute since 1992 until 2000, including Principle Scientist. From December 2003 to November 2018, Dr. Hattersley held roles of increasing seniority at Radius Health Inc. Dr. Hattersley received a Ph.D. from St. George’s Hospital Medical School in London and a BSc from the University of Hull.

Positions